PURE BIOSCIENCE, INC. (PURE)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 07-31. Amounts in USD.

Revenue Annual

0 2.5M 5M 7.5M FY11: 464K FY12: 812K FY17: 1.8M FY18: 1.8M FY19: 1.9M FY20: 6.9M FY21: 3.9M FY22: 1.9M FY23: 1.9M FY24: 2M FY25: 2.2M FY11 FY12 FY17 FY18 FY19 FY20 FY21 FY22 FY23 FY24 FY25

Gross Profit Annual

0 1.5M 3M 4.5M FY19: 1.2M FY20: 4M FY21: 2.1M FY22: 1M FY23: 971K FY24: 1.2M FY25: 1.3M FY19 FY20 FY21 FY22 FY23 FY24 FY25

Operating Income Annual

-15M -10M -5M 0 5M 10M 15M FY11: -8.4M FY12: -8.8M FY13: -7.3M FY14: -11.9M FY15: -7.6M FY16: -7.1M FY17: -6M FY18: -7M FY19: -5.6M FY20: 4K FY21: -2.3M FY22: -3.7M FY23: -3.9M FY24: -3.2M FY25: -2.3M FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Net Income Annual

-15M -10M -5M 0 5M 10M 15M FY11: -8.3M FY12: -8.9M FY13: -7.7M FY14: -11.1M FY15: -7.6M FY16: -14.4M FY17: -6.3M FY18: -7.4M FY19: -6.6M FY20: 4K FY21: -2.3M FY22: -3.5M FY23: -4M FY24: -3.4M FY25: -2.4M FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Cost of Revenue Annual

0 1M 2M 3M FY17: 760K FY18: 763K FY19: 728K FY20: 2.9M FY21: 1.9M FY22: 853K FY23: 906K FY24: 811K FY25: 899K FY17 FY18 FY19 FY20 FY21 FY22 FY23 FY24 FY25

Operating Cash Flow Annual

-7.5M -5M -2.5M 0 2.5M 5M 7.5M FY11: -6.1M FY12: -5.6M FY13: -3.9M FY14: -6.3M FY15: -6.1M FY16: -5M FY17: -4.6M FY18: -3.9M FY19: -3M FY20: 669K FY21: -1.2M FY22: -2.4M FY23: -3.3M FY24: -2.5M FY25: -2M FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Free Cash Flow Annual

-7.5M -5M -2.5M 0 2.5M 5M 7.5M FY11: -6.1M FY12: -5.6M FY13: -3.9M FY14: -6.3M FY15: -6.1M FY16: -5.4M FY17: -4.8M FY18: -3.9M FY19: -3M FY20: 611K FY21: -1.7M FY22: -2.5M FY23: -3.3M FY11 FY13 FY15 FY17 FY19 FY21 FY23

Operating cash flow minus capital expenditure.

Shares Outstanding Annual

0 40M 80M 120M FY19: 72.9M FY20: 84.6M FY21: 87.2M FY22: 88.8M FY23: 111.4M FY24: 111.9M FY25: 111.9M FY19 FY20 FY21 FY22 FY23 FY24 FY25

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-3.00 -2.00 -1.00 0.00 1.00 2.00 3.00 Q4 '11: -1.80 Q1 '12: -2.21 Q2 '12: -2.55 Q3 '12: -2.81 Q4 '12: -1.59 Q1 '13: -1.37 Q2 '13: -1.13 Q3 '13: -0.96 Q4 '13: -0.74 Q1 '14: -0.68 Q2 '14: -0.61 Q3 '14: -0.54 Q4 '14: -0.45 Q1 '15: -0.31 Q2 '15: -0.25 Q3 '15: -0.23 Q4 '15: -0.18 Q1 '16: -0.20 Q2 '16: -0.35 Q3 '17: -0.04 Q4 '17: -0.10 Q1 '18: -0.11 Q2 '18: -0.13 Q3 '18: -0.12 Q4 '18: -0.11 Q1 '19: -0.11 Q2 '19: -0.10 Q3 '19: -0.11 Q4 '19: -0.10 Q1 '20: -0.07 Q2 '20: -0.06 Q3 '20: -0.02 Q4 '20: 0.00 Q1 '21: 0.01 Q2 '21: 0.01 Q3 '21: -0.01 Q4 '21: -0.03 Q1 '22: -0.04 Q2 '22: -0.04 Q3 '22: -0.04 Q4 '22: -0.04 Q1 '23: -0.04 Q2 '23: -0.05 Q3 '23: -0.05 Q4 '23: -0.05 Q1 '24: -0.05 Q2 '24: -0.04 Q3 '24: -0.04 Q4 '24: -0.03 Q1 '25: -0.03 Q2 '25: -0.03 Q3 '25: -0.03 Q4 '25: -0.03 Q1 '26: -0.02 Q2 '26: -0.02 Q3 '26: -0.02 Q2 '13 Q1 '15 Q4 '17 Q3 '19 Q2 '21 Q1 '23 Q4 '24 Q3 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.